VetBloom Continues to Show Strong Growth


Expands Service to Asia and Forms Innovative Partnerships with ONCORE ePD and David Liss, RVT of Veterinary Training and Consulting

WOBURN, Mass.–(BUSINESS WIRE)–VetBloom, the cutting-edge, continuing education platform from Ethos Veterinary Health (Ethos), continues to rapidly expand its offerings and reach. VetBloom recently formed new partnerships with ONCORE ePD and David Liss, RVT, VTS (ECC, SAIM), CVPM, and is now launching in Asia in partnership with Veterinary Specialty Hospital (VSH) of Hong Kong, the first dedicated veterinary specialty hospital in the region.

Launching in June, VetBloom Asia contains popular and well-designed learning resources, tailored specifically to meet the needs of veterinary professionals at every stage of their career. Patrick Welch, DVM, MBA, DACVO, Chief Knowledge Officer of Ethos, explains why the Asian market is of particular interest. “We are seeing big changes in the way that veterinary professionals are able to access professional development resources. As many countries in Asia increase their adoption of formal continuing education requirements, the natural next step for VetBloom is to deliver innovative educational resources to the international veterinary community.”

VetBloom Asia will draw on the success of VetBloom’s U.S. operations together with the regional knowledge, relationships, and operating experience of the VSH Hong Kong team. “Veterinary continuing education is becoming more and more prevalent and easier to access as the demand from veterinary professionals grows,” said Dr. Alane Cahalane, CEO of VSH Hong Kong. “What’s really needed is a high caliber, comprehensive, up-to-date educational platform which can help to standardize the levels of professional knowledge in Asian countries. VetBloom Asia comprehensively fulfills those needs,” she continued.

On June 21st, 2017, in Quezon City, Philippines, Dr. Cahalane will deliver a complimentary learning event sponsored by VetBloom Asia for veterinary professionals in the area. For information and reservations please contact

VetBloom also recently entered into partnerships with U.K.-based education provider, ONCORE ePD and David Liss, RVT. Since 2011, ONCORE ePD has been a pioneer of tutor-led, interactive online veterinary education covering a diverse range of subjects. ONCORE founder, Jill Macdonald, Dip AVN (Surg), RVN, FHEA, first became aware of VetBloom shortly after its launch in 2015 and has kept abreast of developments since that time. “I’m really impressed with the VetBloom learning platform and the commitment to quality and consistency of education offered,” said Macdonald. The product team, led by Jeffrey Johnson, M.Ed., has done excellent work and we are delighted to have the opportunity to collaborate.”

Dr. Welch sees great value in working with Jill and ONCORE within the context of a partnership. “Student feedback from ONCORE courses is fantastic and learners really appreciate the tutor mentorship and communication throughout. This type of online learning is not as prevalent in the U.S., and we’re excited to be working with Jill and ONCORE to launch these first modules,” he said.

Two instructor led modules – Patient-Friendly Practice: Dogs and Patient-Friendly Practice: Cats are currently in development for North American distribution and are scheduled for release in Q4 2017. For more information and to pre-register, please email

David Liss, RVT, VTS (ECC, SAIM), CVPM is a renowned technician educator, lecturing internationally, authoring numerous articles and book chapters, and serving on various technician association committees. The partnership with David creates a unique synergy between his expertise and content, and the technology, online community and international reach of the VetBloom platform. This collaboration will allow VetBloom to offer more premium webinars and on-demand training for veterinary technicians and assistants.

About VetBloom

VetBloom is an innovative learning ecosystem featuring the expertise of the finest veterinary professionals in the industry, along with cutting-edge online instruction. Team members learn through direct and virtual instruction, interactive case-based scenarios and 3D simulations. VetBloom allows veterinary professionals to advance their skills from anywhere in the world. For more information visit

About Ethos Veterinary Health

Ethos is a veterinary health company with fourteen locations across the U.S. providing advanced medical care for pets. Our approach includes a focus on transformative science, continuous learning and growth for team members and collaboration. For more information visit

ACI and Ethos Veterinary Health Form New Clinical Trial Network


New Opportunity for Rapid Approval of Innovative Therapies for the Animal Health Market

WOBURN, Mass. (March 8, 2017) — Animal Clinical Investigation (ACI) and Ethos Veterinary Health (Ethos) have formed a strategic alliance offering a new mechanism to deliver market approval of pharmaceuticals and therapeutics in Animal Health. This relationship offers a unique opportunity for collaboration with organizations in the pharmaceutical industry, diagnostic developers and medical device companies.

The two companies are establishing a multi-specialty clinical trial network comprised of a geographically diverse, nationwide collection of Ethos veterinary hospitals. They are selected based on their interest and experience in clinical research, and their depth and strength in the veterinary specialties of internal medicine, dermatology, oncology, emergency and critical care medicine, diagnostic imaging and surgery.

“This is an exciting partnership for Ethos. It will ensure that we are on the forefront of medical discoveries through the participation of our motivated doctors trained in the rigor of conducting clinical trials by ACI, a leading group in veterinary medicine that oversees trial delivery.”

Keith Richter, DVM, MSEL, DACVIM
Chief Medical Officer

ACI, focused on complex medical problems in animals and the design and execution of clinical trials, has been a leader in bringing clinical trials into the private practice setting. Adding the Ethos multi-specialty trial network to ACI’s previously assembled group expands its reach beyond oncology and dermatology.

“Speaking on the new ACI-Ethos clinical trial network, Kristen Khanna, PhD, MBA, stated that, “We look forward to continuing to expand ACI’s role in clinical trial conduct in specialty medicine by joining with Ethos investigators and their staff.  Ethos already practices medicine at the highest level – this opportunity allows Ethos and ACI to share our science-driven mindset with study sponsors and pet owners.”

Kristen Khanna, PhD, MBA
ACI Chief Executive Officer

The opportunity for rapid and successful approval of innovative therapies is a key benefit to study sponsors, based on the following:

  • Rapid accrual of data, resulting in faster studies, is enabled by the substantial caseload offered by the Ethos network and the optimized trial participation through ACI’s management
  • Highly motivated and experienced clinicians and medical monitoring ensure quality data
  • Ethos’ strategic focus on scientific innovation

Clinical studies in the areas of orthopedics, pain management, gastrointestinal disorders, immune mediated disease, oncology and the management of sepsis in dogs are currently being planned and will be among the first to be launched by the new ACI-Ethos multi-specialty network.

Ethos Diagnostic Science Conducts Accuracy Testing for Samsung

, ,

Ethos Diagnostic Science was recently contracted by Samsung to study the accuracy of the new PT10V blood analyzer as Samsung prepared to enter the US Animal Health market. The small, point-of-care chemistry analyzer had been evaluated by Samsung in Korea prior to then, but it had not been studied against any reference standards.

Using industry recommendations for the validation of new laboratory assays methods, Ethos Diagnostic Science compared all instruments by testing several hundred canine, feline and equine blood specimens covering a wide range of values. Standard statistical methods for evaluating correlation – comparing the accuracy of the new analyzer with results obtained, on the same samples, from the reference analyzers – were utilized. The results showed excellent and acceptable data for all of the dog and cat samples, and nearly all of the horse specimens.

Dr. Andrew Loar, Vice President of Laboratories for Ethos Veterinary Health, said, “Of the hundreds of samples evaluated during the study, no operative or functional errors occurred, showing consistent and reliable results.” The findings were also useful for establishing the analyzer’s reference intervals (normal ranges) for all three species.

This was part of a collaborative effort between Samsung and Henry Schein.  … Read this article

Citizens Bank Provides $21MM Facility to Ethos Veterinary Health

Ethos formed as the result of the recent merger of four specialty hospital groups: IVG Hospitals (New England), Premier Veterinary Group (Chicago), Wheat Ridge Animal Hospital (Denver) and Veterinary Specialty Hospital of San Diego. The company provides specialty and emergency care for pets through its 13 hospital locations across the U.S. Read this article

New Hospital Network Known as Ethos Veterinary Health


With 13 hospitals from coast to coast, Ethos has not ruled out expansion.
Ethos is made up of 13 referral hospitals stretching from the northeastern United States to Southern California. Each location will retain the name of its respective group: IVG Hospitals, Premier Veterinary Group, Wheat Ridge Animal Hospital and Veterinary Specialty Hospital… Read this article